Novel approaches for the management of primary hyperparathyroidism during pregnancy
Xiuzhen Zhang
Department of Endocrinology and Metabolism, Shenzhen People's Hospital, The Second Affiliated Hospital of Jinan University, Shenzhen, China
Search for more papers by this authorNan Xu
Department of Thyroid Surgery, Shenzhen People's Hospital, The Second Affiliated Hospital of Jinan University, Shenzhen, China
Search for more papers by this authorYan Wu
Department of Endocrinology and Metabolism, Shenzhen People's Hospital, The Second Affiliated Hospital of Jinan University, Shenzhen, China
Search for more papers by this authorBing Huang
Department of Endocrinology and Metabolism, Shenzhen People's Hospital, The Second Affiliated Hospital of Jinan University, Shenzhen, China
Search for more papers by this authorXinjie Liu
Department of Thyroid Surgery, Shenzhen People's Hospital, The Second Affiliated Hospital of Jinan University, Shenzhen, China
Search for more papers by this authorCorresponding Author
Fengyi Yuan
Department of Endocrinology and Metabolism, Shenzhen People's Hospital, The Second Affiliated Hospital of Jinan University, Shenzhen, China
Correspondence Fengyi Yuan, Shenzhen People's Hospital, No. 1017 Dongmen North Road, Shenzhen, Guangdong 518020, China Email: [email protected]Search for more papers by this authorXiuzhen Zhang
Department of Endocrinology and Metabolism, Shenzhen People's Hospital, The Second Affiliated Hospital of Jinan University, Shenzhen, China
Search for more papers by this authorNan Xu
Department of Thyroid Surgery, Shenzhen People's Hospital, The Second Affiliated Hospital of Jinan University, Shenzhen, China
Search for more papers by this authorYan Wu
Department of Endocrinology and Metabolism, Shenzhen People's Hospital, The Second Affiliated Hospital of Jinan University, Shenzhen, China
Search for more papers by this authorBing Huang
Department of Endocrinology and Metabolism, Shenzhen People's Hospital, The Second Affiliated Hospital of Jinan University, Shenzhen, China
Search for more papers by this authorXinjie Liu
Department of Thyroid Surgery, Shenzhen People's Hospital, The Second Affiliated Hospital of Jinan University, Shenzhen, China
Search for more papers by this authorCorresponding Author
Fengyi Yuan
Department of Endocrinology and Metabolism, Shenzhen People's Hospital, The Second Affiliated Hospital of Jinan University, Shenzhen, China
Correspondence Fengyi Yuan, Shenzhen People's Hospital, No. 1017 Dongmen North Road, Shenzhen, Guangdong 518020, China Email: [email protected]Search for more papers by this author
REFERENCES
- 1Schnatz PF, Curry SL. Primary hyperparathyroidism in pregnancy: evidence-based management. Obstet Gynecol Surv. 2002; 57(6): 365-376.
- 2McMullen TP, Learoyd DL, Williams DC, et al. Hyperparathyroidism in pregnancy: options for localization and surgical therapy. World J Surg. 2010; 34(8): 1811-1816.
- 3Ozderya A, Temizkan S, Cetin K, Ozugur S, Gul AE, Aydin K. The results of parathyroid hormone assay in parathyroid aspirates in pre-operative localization of parathyroid adenomas for focused parathyroidectomy in patients with negative or suspicious Technetium-99 m-sestamibi scans. Endocr Pract. 2017; 23(9): 1101-1106.
- 4Zeng H, Li Z, Zhang X, Wang N, Tian Y, Wang J. Anesthetic management of primary hyperparathyroidism during pregnancy: a case report. Medicine (Baltimore). 2017; 96(51): e9390.
- 5Sormaz IC, Poyanlı A, Açar S, et al. The results of ultrasonography-guided percutaneous radiofrequency ablation in hyperparathyroid patients in whom surgery is not feasible. Cardiovasc Intervent Radiol. 2017; 40(4): 596-602.
Citing Literature
